Harlow, United Kingdom

Garry Fenton

USPTO Granted Patents = 12 

Average Co-Inventor Count = 9.3

ph-index = 4

Forward Citations = 36(Granted Patents)


Location History:

  • Essex, GB (2008)
  • Harlow, GB (2007 - 2011)

Company Filing History:


Years Active: 2007-2011

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Inventive Legacy of Garry Fenton

Introduction:

Garry Fenton, a visionary inventor based in Harlow, GB, is renowned for his relentless passion for innovation and his commitment to shaping the future of technology. With 12 patents to his name, Fenton's work continues to resonate in the realm of inventions.

Latest Patents:

1. Compound of formula (III): A recent patent by Garry Fenton introduces a compound of formula (III), offering insights into cutting-edge chemical compositions with diverse applications.

2. Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators: Another notable patent reveals Fenton's advancements in pharmaceutical compositions for treating inflammatory and allergic conditions.

Career Highlights:

Having made significant contributions to the field of inventing, Garry Fenton has left an indelible mark on companies like Asterand UK Limited and Pharmagene Laboratories Limited. His innovative spirit and dedication have led to groundbreaking advancements within these organizations.

Collaborations:

Throughout his career, Garry Fenton has collaborated with esteemed colleagues such as Alexander W Oxford and Richard Jon Davis. Together, they have spearheaded projects that have redefined the boundaries of innovation in their respective fields.

Conclusion:

In conclusion, Garry Fenton's unwavering commitment to pushing the boundaries of innovation and technology has cemented his status as a visionary inventor. His inventions continue to inspire and shape the landscape of technological advancements, leaving a lasting legacy in the world of patents and inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…